Orthofix Medical Inc.
OFIX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000884624
In the last 90 days, Orthofix Medical Inc. insiders filed 1 open-market purchase and 5 sales; 143 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 10, 2026, 1:13 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $92.2M (11.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Cost of revenue | $256.3M | $253.6M | $260.4M | $123.5M | $114.9M |
| Gross profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M |
| Research and development | $65.8M | $73.6M | $80.2M | $49.1M | $49.6M |
| Selling, general and administrative | $554.3M | $532.5M | $144.7M | $80.0M | $69.4M |
| Operating income | -$81.4M | -$84.6M | -$139.1M | -$13.3M | -$8.31M |
| Income tax | $1.38M | $2.12M | $2.72M | $2.04M | $24.9M |
| Net income | -$92.2M | -$126.0M | -$151.4M | -$19.7M | -$38.4M |
| EPS, basic | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
| EPS, diluted | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
| Weighted shares, basic | 39.6M | 38.1M | 36.7M | 20.1M | 19.7M |
| Weighted shares, diluted | 39.6M | 38.1M | 36.7M | 20.1M | 19.7M |
| Margins and growth | |||||
| Gross margin | 68.8% | 68.3% | 65.1% | 73.2% | 75.3% |
| Operating margin | -9.9% | -10.6% | -18.6% | -2.9% | -1.8% |
| Net margin | -11.2% | -15.8% | -20.3% | -4.3% | -8.3% |
| Revenue growth, year over year | +2.9% | +7.1% | +62.1% | −0.8% | +14.2% |
| Net income growth, year over year | – | – | – | – | −1,624.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Cash and equivalents | $82.0M | $83.2M | $33.1M | $50.7M | $87.8M |
| Accounts receivable | $135.7M | $134.7M | $128.1M | $82.9M | $78.6M |
| Inventory | $172.3M | $189.5M | $222.2M | $100.2M | $83.0M |
| Total current assets | $416.8M | $433.3M | $420.4M | $256.0M | $269.5M |
| Property, plant and equipment | $129.4M | $139.8M | $159.1M | $58.2M | $59.3M |
| Goodwill | $194.9M | $194.9M | $194.9M | $71.3M | $71.3M |
| Intangible assets | $72.8M | $98.8M | $117.5M | $47.4M | $52.7M |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M |
| Accounts payable | $58.4M | $48.8M | $58.4M | $27.6M | $26.5M |
| Short-term debt | $0 | – | $1.25M | – | – |
| Total current liabilities | $170.5M | $168.6M | $165.2M | $83.6M | $105.8M |
| Long-term debt | $157.4M | $157.0M | $93.1M | – | – |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M |
| Shareholders' equity | $450.0M | $503.1M | $598.7M | $336.9M | $336.9M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Operating cash flow | $33.3M | $25.8M | -$45.8M | -$11.5M | $18.5M |
| Capital expenditures | $34.6M | $34.9M | $60.3M | $21.4M | $17.8M |
| Free cash flow | -$1.28M | -$9.09M | -$106.0M | -$32.9M | $690.0K |
| Depreciation and amortization | $77.3M | $60.1M | $53.1M | $29.0M | $29.6M |
| Stock-based compensation | $28.7M | $32.5M | $35.7M | $18.4M | $15.4M |
| Investing cash flow | -$34.6M | -$27.6M | -$33.1M | -$24.5M | -$23.0M |
| Financing cash flow | -$786.0K | $50.7M | $65.3M | -$78.0K | -$3.62M |
| Net change in cash | -$623.0K | $48.0M | -$12.9M | -$37.1M | -$8.97M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.5% | 4.1% | 4.8% | 4.0% | 3.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 5, 2026 | 40.8M | +2.9% | SEC |
| Jul 31, 2026 | 40.7M | +3.1% | SEC |
| May 1, 2026 | 40.4M | +3.2% | SEC |
| Feb 20, 2026 | 40.1M | +2.9% | SEC |
| Oct 31, 2025 | 39.6M | +3.6% | SEC |
| Jul 31, 2025 | 39.5M | +3.5% | SEC |
| May 2, 2025 | 39.2M | +4.4% | SEC |
| Feb 21, 2025 | 39.0M | +4.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.